XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statement of Shareholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained (Deficit) Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning Balance (in shares) at Dec. 31, 2020   37,552        
Beginning Balance at Dec. 31, 2020 $ 106.8 $ 0.4 $ 193.5 $ (24.0) $ (66.5) $ 3.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 0.4   0.4      
Issuance of restricted stock (in shares)   65        
Issuance of restricted stock 0.0   (1.1) 1.1    
Stock withheld for employee taxes (in shares)   (47)        
Stock withheld for employee taxes (1.9)     (1.9)    
Proceeds from issuance of common stock (in shares)   119        
Proceeds from issuance of common stock 2.3   (0.2) 2.5    
Issuance of shares under employee stock purchase plan (in shares)   29        
Issuance of shares under employee stock purchase plan 0.5   0.5      
Dividends (6.0)       (6.0)  
Change in cumulative translation adjustment 0.1         0.1
Net income 15.2       15.2  
Ending Balance (in shares) at Mar. 31, 2021   37,718        
Ending Balance at Mar. 31, 2021 117.4 $ 0.4 193.1 (22.3) (57.3) 3.5
Beginning Balance (in shares) at Dec. 31, 2021   37,854        
Beginning Balance at Dec. 31, 2021 153.6 $ 0.4 195.8 (20.4) (25.5) 3.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 1.0   1.0      
Issuance of restricted stock (in shares)   22        
Issuance of restricted stock 0.0   (0.4) 0.4    
Stock withheld for employee taxes (in shares)   (11)        
Stock withheld for employee taxes (0.4)     (0.4)    
Proceeds from issuance of common stock (in shares)   29        
Proceeds from issuance of common stock 0.7   0.1 0.6    
Issuance of shares under employee stock purchase plan (in shares)   23        
Issuance of shares under employee stock purchase plan 0.6   0.6      
Dividends (6.8)       (6.8)  
Change in cumulative translation adjustment 0.1         0.1
Net income 22.0       22.0  
Ending Balance (in shares) at Mar. 31, 2022   37,917        
Ending Balance at Mar. 31, 2022 $ 170.8 $ 0.4 $ 197.1 $ (19.8) $ (10.3) $ 3.4